Purchase Order 36C24225P1042
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$11K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Pantherx Specialty, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15205, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a $10,897.20 firm fixed price purchase order contract to Pantherx Specialty, LLC, a specialty pharmacy focused on rare diseases, to provide the drug TARPEYO (budesonide) 4mg for an emergency requirement at the New York Harbor VA healthcare facilities. The contract has an ultimate completion date of March 5, 2025. No set-aside designation was used for this award. Pantherx Specialty, a subsidiary of Centene Corporation, is an experienced...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of the prescription medication Tarpeyo 4mg capsules to VA facilities within Veterans Integrated Service Network 2. The contract has a total ceiling value of $10,638.00 and runs through March 20, 2025. There is no set-aside designation associated...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the pharmaceutical product Ruzurgi [amifampridine] to Veterans Integrated Service Network 16 facilities. The contract has a potential value of $119,339.01 and a completion date of September 30, 2020. Pantherx Specialty is a subsidiary of Centene Corporation that operates as a specialty pharmacy focused...
This federal contract award, with a ceiling value of $85,242.15, was issued by the Department of Veterans Affairs Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is a firm fixed price purchase order for the supply of the drug Ruzurgi (amifampridine 10mg) to VA facilities within VISN 16. This contract supports the medical needs of veterans obtaining care through the VA health system. No set-aside designation...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a subsidiary of Centene Corporation, to provide the drug Ruzurgi 10mg. The contract has a ceiling value of $85,242.15 and an ultimate completion date of February 13, 2022. No set-aside designation was used for this award. Pantherx Specialty, a specialty pharmacy focused on rare diseases, has received multiple federal contracts from the...
This federal contract award is for the delivery of TARPEYO, a specialized pharmaceutical product, to the Department of Veterans Affairs (VA). The prime contractor, Calliditas Therapeutics US Inc., is a foreign-owned, for-profit pharmaceutical company that has established itself as a key supplier of TARPEYO to VA medical centers and clinics nationwide. The contract, awarded on March 12, 2024, is a delivery order under Calliditas Therapeutics US Inc.'s Federal Supply Schedule (FSS) contract for...
This federal contract award is for third-party first fill pharmacy (RX) services, with a ceiling value of $202,935.26. The contract was awarded to Palisade-Heritage JV LLC, a veteran-owned small business, by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 20 (VISN 20). The contract has a period of performance through May 31, 2023 and is structured as a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The contract was set...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] for the Boro VAMC Pharmacy. The contract, valued at $6,048.81, was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and has a completion date of April 2024. This delivery order was not set aside for any specific socioeconomic category. Ardelyx currently holds...
The U.S. Department of Veterans Affairs (VA) awarded a $14,129.48 Blanket Purchase Agreement (BPA) call contract to Palisade-Heritage JV LLC, a veteran-owned small business, for third-party administration of pharmaceutical prescription benefits services. The contract, which has a performance period through March 31, 2025, was awarded under the VA's Veterans Integrated Service Network 5 (VISN 5) to provide pharmacy benefit management, medication counseling, and related healthcare services for...
This federal contract award to Palisade-Heritage JV LLC, a veteran-owned and service-disabled veteran-owned small business, is for the third-party administration of insurance for pharmaceutical prescription benefits services. The $94,528.39 firm fixed price contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 5 on April 1, 2022, with a performance period through March 31, 2023. The contract is a blanket purchase agreement (BPA) call, which...